Research Center Pharmaceutical Engineering, Graz, Austria; Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, NAWI Graz, Graz, Austria.
FEBS J. 2015 Feb;282(3):562-78. doi: 10.1111/febs.13162. Epub 2014 Dec 16.
Aerococcus viridansl-lactate oxidase (avLOX) is a biotechnologically important flavoenzyme that catalyzes the conversion of L-lactate and O₂ into pyruvate and H₂O₂. The enzymatic reaction underlies different biosensor applications of avLOX for blood L-lactate determination. The ability of avLOX to replace O₂ with other electron acceptors such as 2,6-dichlorophenol-indophenol (DCIP) allows the possiblity of analytical and practical applications. The A95G variant of avLOX was previously shown to exhibit lowered reactivity with O₂ compared to wild-type enzyme and therefore was employed in a detailed investigation with respect to the specificity for different electron acceptor substrates. From stopped-flow experiments performed at 20 °C (pH 6.5), we determined that the A95G variant (fully reduced by L-lactate) was approximately three-fold more reactive towards DCIP (1.0 ± 0.1 × 10(6) M(-1) ·s(-1) ) than O₂, whereas avLOX wild-type under the same conditions was 14-fold more reactive towards O₂(1.8 ± 0.1 × 10(6) m(-1) ·s(-1)) than DCIP. Substituted 1,4-benzoquinones were up to five-fold better electron acceptors for reaction with L-lactate-reduced A95G variant than wild-type. A 1.65-Å crystal structure of oxidized A95G variant bound with pyruvate was determined and revealed that the steric volume created by removal of the methyl side chain of Ala95 and a slight additional shift in the main chain at position Gly95 together enable the accomodation of a new active-site water molecule within hydrogen-bond distance to the N5 of the FMN cofactor. The increased steric volume available in the active site allows the A95G variant to exhibit a similar trend with the related glycolate oxidase in electron acceptor substrate specificities, despite the latter containing an alanine at the analogous position.
微球菌酮-乳醇氧化酶(avLOX)是一种具有生物技术重要性的黄素氧化酶,可催化 L-乳酸和 O₂转化为丙酮酸和 H₂O₂。avLOX 的酶促反应是其用于血液 L-乳酸测定的不同生物传感器应用的基础。avLOX 能够用其他电子受体(如 2,6-二氯酚靛酚(DCIP))代替 O₂,这使得分析和实际应用成为可能。先前已经表明,avLOX 的 A95G 变体与野生型酶相比,对 O₂的反应性降低,因此在详细研究不同电子受体底物的特异性时,使用了该变体。从在 20°C(pH 6.5)下进行的停流实验中,我们确定 A95G 变体(被 L-乳酸完全还原)对 DCIP(1.0 ± 0.1×10^6^ M^-1^·s^-1^)的反应性大约是 O₂的三倍,而在相同条件下,avLOX 野生型对 O₂(1.8 ± 0.1×10^6^ m^-1^·s^-1^)的反应性则是 DCIP 的 14 倍。取代的 1,4-苯醌作为与 L-乳酸还原的 A95G 变体反应的电子受体,其活性比野生型高五倍。测定了氧化的 A95G 变体与丙酮酸结合的 1.65-Å 晶体结构,结果表明,通过去除丙氨酸 95 的甲基侧链和主链位置 Gly95 的轻微额外移动,创造了一个新的活性部位水分子的空间,该水分子与 FMN 辅因子的 N5 形成氢键。在活性部位中增加的可用空间体积使 A95G 变体在电子受体底物特异性方面表现出与相关的乙醇酸氧化酶相似的趋势,尽管后者在类似位置含有丙氨酸。